Start With the Exact Diagnosis, Not the Category
Head and neck cancer is a category, not a single disease. It covers tumours arising in different sites, such as the oral cavity, pharynx, larynx, salivary glands, nasal cavity and sinuses. Each site has its own anatomy, its own staging logic and its own treatment options. The National Cancer Institute notes that head and neck cancers include different tumour sites and that the exact diagnosis should be identified before treatment options are discussed.
That is why the first question for any multidisciplinary discussion is not "what treatment do you recommend?" but "what exactly is this?" The team should be able to state the primary site, the histological type, the grade where relevant, and the stage based on the imaging and pathology already available. If the site or the pathology is still uncertain, that uncertainty should be named rather than smoothed over.
For an overseas patient, this matters practically. A plan built on an unclear primary site can lead to the wrong operation, the wrong radiation field or the wrong systemic therapy. Before you ask a Chinese hospital to review your case, make sure your own records state the diagnosis as precisely as your current clinicians can. If they cannot, say so in your enquiry; a review can still discuss what is missing and what would clarify it.
A useful MDT answer here is specific: it names the site, the type and the stage, and it says which of those is confirmed and which is provisional. A vague answer that only repeats "head and neck cancer" does not give you a decision you can act on.
Pathology Review: What the Slides and Reports Actually Show
Pathology drives treatment in head and neck cancer more than almost anything else. The report should describe the tumour type, the grade, the presence or absence of certain markers where relevant, and whether margins or nodes were assessed if there has already been surgery. If you have had a biopsy or resection elsewhere, the original slides and blocks are the most useful material a reviewing team can examine.
Ask the MDT to answer three things about pathology. First, does the reviewing pathologist agree with the original diagnosis? Second, is any additional testing needed to answer a specific treatment question? Third, does the pathology change the stage or the options? A review that only confirms the diagnosis without explaining its consequences for your decision is less useful than one that states what the findings mean for the plan.
There is a limit here. A pathology review is a records-based assessment. It can clarify what the tissue shows, but it cannot by itself confirm that a particular operation is suitable for you, that a hospital will accept you, or that a treatment is available on a given date. Those are separate questions for the treating team and the hospital.
If you are sending records to China, ask how pathology material should be transferred, whether the hospital wants slides, blocks or digital images, and what it can and cannot conclude from what you send. Do not assume that a scanned report is equivalent to the original material for every question.
Previous Treatment Changes Every Option
Whether you have had surgery, radiotherapy, chemotherapy, immunotherapy or a combination changes what is possible now. Prior radiotherapy, in particular, affects tissue healing and can limit further radiation to the same area. Prior surgery changes the anatomy and may affect reconstruction options. Prior systemic therapy may affect which drugs remain reasonable.
The MDT should therefore answer: what treatment have you already had, when, at what dose or extent where known, and how did you respond? It should also say whether the previous treatment was completed as planned or stopped early, and why. These details are not administrative trivia; they directly shape what a new team can safely propose.
Ask the team to state explicitly whether the new plan is a first-line treatment, a salvage or recurrence plan, or a plan for a second primary. These are different clinical situations and they lead to different discussions. If your records do not make this clear, the review should say so rather than assume.
For patients considering care in China, one practical question is whether the Chinese team would want to repeat any staging or testing before deciding. That is a clinical judgement for the treating team. Ask what they would need and why, rather than assuming that existing imaging is sufficient or that everything must be repeated.
Speech, Swallowing and Function: Goals Before Techniques
Head and neck treatment can affect voice, swallowing, breathing and appearance. These are not afterthoughts; they are part of the decision. The MDT should ask what matters most to you and what the realistic range of functional outcomes is for the options under discussion. That conversation belongs before a technique is chosen, not after.
Ask the team to explain, in plain terms, how each option could affect your ability to speak, eat and breathe, and what rehabilitation or support might be involved. Ask whether a speech and language therapist or a dietitian is part of the discussion. If the answer is that these specialties are not involved, that is useful information about the scope of the review.
Be careful about promises. No team can guarantee that a function will be preserved. What a good discussion can do is explain the trade-offs, the uncertainties and the factors that make one option more or less suitable for you. If you hear a guarantee, ask what it is based on.
This is also where your own priorities belong. If preserving voice is more important to you than a particular surgical margin, say so. If you are more concerned about swallowing than about the length of treatment, say so. The MDT cannot weigh your values for you, but it can tell you what each choice is likely to mean.
What the MDT Should State, and What It Cannot Decide
A useful MDT summary should state the diagnosis and stage as understood, the treatment options considered, the recommended option and the reasoning, the alternatives and why they were not preferred, and the main uncertainties. It should also say what further information would change the recommendation. If the summary does not include these elements, ask for them.
It should also be clear about what the discussion cannot do. A records-based MDT review does not examine you in person. It cannot confirm your fitness for a particular anaesthetic or operation, and it cannot guarantee that a hospital will accept you or that a treatment will be available when you arrive. Those decisions belong to the treating hospital and its clinicians after they assess you.
Ask who took part. A discussion involving surgery, radiation oncology, medical oncology, pathology and radiology is different from a single specialist's opinion. If the format is a tumour board, ask how often it meets and how your case would be presented. If the hospital does not use this format, ask what it does instead and who reviews complex cases.
Finally, ask for the conclusion in writing. A written summary you can read, translate and discuss with your local clinicians is more useful than a verbal impression. It also gives you a record of what was said and what remained open.
Confirming the Process Before You Travel
Not every hospital offers a multidisciplinary discussion in the same way, and some may not use that format at all. Before you plan travel, ask the specific hospital how complex head and neck cases are reviewed, which specialties are involved, and whether you would be discussed before or after an in-person assessment. Ask what records they need and how they prefer to receive them.
If you are working with a coordination service, be clear about what is being arranged. An initial enquiry can help identify what information is missing and what the next step might be. A records-based specialist opinion or a multidisciplinary review can be arranged for complex cases, with the scope and fee agreed first. These are separate from hospital consultation and treatment charges, and they do not guarantee acceptance or a particular outcome.
For head and neck cancer specifically, the relevant procedure reference on this site is head and neck tumour surgery. It describes the surgical side of care; the MDT questions above are about how a team reaches and explains a decision, which is a different task.
Keep your own local care in place while you explore options abroad. If your symptoms worsen, seek local assessment rather than waiting for an overseas reply. An enquiry is not a substitute for urgent care.
A practical next step is to gather your pathology report, imaging reports, operative notes if any, and a short summary of previous treatment, then send a brief enquiry. The initial review is free and non-clinical; it checks what you have and suggests what to clarify next.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.